Purpose. Due to numerous advantages of the combination of clindamycin and gentamicin in polymethylmethacrylate (PMMA) cement, promising preliminary results have been reported. However, there are no data that analyse mid-term outcomes.
INTRODUCTION
Antibiotic-loaded bone cement (ALBC) is embedded in the concept of surgical management of periprosthetic joint infection (PJI), and is one of the treatment options during one-stage exchange procedures [1] . The main advantage of ALBC, unlike the systemic antibiotic (AB) therapy, is the initially very high and effective local concentration of the AB at the implant-cement-bone interface without significant systemic burden [2] . Arthroplasty register data have already shown lower PJI rates following primary total hip arthroplasty (THA) procedures utilizing ALBC [3] . Likewise, an approximately 50 % decrease of the infection rate in primary THA with the use of ALBC has been reported in a meta-analysis including 19 studies reporting on 36.033 hip replacements [4] . The use of dual ALBC is recommended for revision arthroplasty, in particular for patients who are at higher risk of infection [5, 6] . Malhotra et al. described revision cements first, which contain more than one antimicrobial substance with drugs making up more than 2.5 % drugs of the cement volume [7] . The main goal in the prophylactic use is to prevent bacteria from colonizing the surface of the prosthesis [8] . Bone cement can be impregnated with aminoglycosides, glycopeptides, b-lactams, lipopeptides or oxazolidinones. Numerous in vivo and in vitro studies, addressing the local effectiveness of many ALBC types, showed different results. However, clinical reports on midterm to long-term follow-up are limited [9] . Gentamicin is generally chosen because of its controlled diffusion out of the cement mantle and its broad-spectrum bactericidal effect against a wide variety of bacterial contaminants [10, 11] . However, it has been observed that the presence of two ABs with different mechanisms of actions rules out the risk of the development of concomitant resistance to these two substances [7, 10, 11] . The combination of clindamycin and gentamicin is the most appropriate local antibiotic therapy in both one-and two-stage revisions because most pathogens causing PJI have a susceptibility pattern covered by these agents [12] . Among these, Staphylococcus aureus and coagulase-negative staphylococci are responsible for 24-43 % and 12-26 % of PJIs, respectively [13] . In addition, the release of gentamicin appears to be enhanced by the release of clindamycin due to the reciprocally increased elution from the antibiotic-loaded polymethylmethacrylate (PMMA) leading to better diffusion of both ABs which results in a stronger antimicrobial effect [10, 11, 14] .
Moreover, bone cements loaded with combinations of gentamicin and clindamycin or fusidic acid are more effective against biofilm formation than bone cements containing gentamicin alone [15] . The present study aimed to evaluate the efficacy of gentamicin-and clindamycin-loaded (G+C) cement with respect to the eradication of PJI as well as the prevention of infection in high-risk patients at a midterm follow-up.
METHODS
We conducted this pilot study after approval from our local ethics committee. A total of 108 patients underwent primary or revision arthroplasty using Copal G+C (Heraeus Medical, Wehrheim, Germany), as an antibiotic-loaded PMMA cement. All procedures were performed in 2010 at our institution. The patients were divided into two groups: (1) the PJI group comprising patients who underwent one-stage exchange arthroplasty and (2) aseptic group, comprising patients who underwent aseptic revision or primary arthroplasty procedures, but were considered to be high risk patients for infection due to the following reasons: previous PJI, history of osteomyelitis or septic arthritis, previous multiple revision arthroplasty, prior non orthopaedic operations of the same extremity, such as a previous vascular surgery that might be associated with diminished tissue perfusion, or a general comorbidity.
Antibiotic-loaded bone cement
In all patients, premixed Copal G+C (Heraeus Medical, Wehrheim, Germany), was used as an antibiotic-loaded PMMA cement, for the purpose of anchoring as well as a local antibiotic delivery system. The antibiotic component consists of 1 g gentamicin and 1 g clindamycin powder per 40 g PMMA cement. To achieve PMMA cement with reduced porosity, the cement components are mixed together in a vacuum. An air-tight system with a rapid build-up of sufficient vacuum in the mixing equipment is used. The stirring times for mixing in a vacuum and without vacuum are the same (30s). The implanted components were stabilized until processing and hardening for a minimum of 12 minutes. According to the microbiological recommendation, vancomycin was added to the PMMA cement in 8 cases (44 %) and ofloxacin was added in 4 cases (22 %) of the PJI group.
Outcome parameters Patient demographics, indication for primary or revision total joint arthroplasty, type and number of prior surgeries, and pre-and intraoperative microorganism in PJI cases were collected from a hospital chart review for all patients. The primary outcome measure was the overall revision rate with a special focus on PJI at a minimum of 5years followup. Furthermore, all complications were documented for both groups. Additionally, the patients were contacted and asked to send us the results of actual laboratory investigations, including blood tests such as C-reactive protein (CRP) and white blood cell count (WBC) values. The last laboratory blood values as well as last available radiographs were analyzed. Due to the advanced age of the patients at the time of surgery at our institution, many of them were lost to follow-up. Fifty-nine patients were not reachable and 12 patients passed away. Five patients refused to participate in the study. The patients were monitored for re-revision for a minimum of 5 years.
Statistical analysis
Descriptive statistics are presented in the form of the number of occurrences and percentage, or mean and standard deviation (sd). All data were processed using statistical analysis software (GraphPad Prism version 5.0d, La Jolla, CA, USA).
RESULTS
For final evaluation, a total of 32 patients in both groups were included. Eighteen patients belonged to the PJI group and 14 to the aseptic group. The mean age for all patients was 72.5 years at the latest follow-up (range: 58 to 84 years). There were 16 females (50 %) and 16 males (50 %). The mean body mass index (BMI) was 31.1 (kg m À2 ) (range from 18 to 42.6, sd=5.6). According to the American Society of Anesthesiologists score (ASA), 62.5 % of the patients had class II and 37.5 % had class III. Regarding the joints that were operated on, 18 knee (56.2 %), 13 hip (40.6 %) and one shoulder (3.1 %) arthroplasty procedures were performed. Among the aseptic group, two primary, three total revisions nine partial total joint arthroplasties with exchange of one prosthesis component were performed. The mean number of prior arthroplasty surgeries for the index joint was 3.2 operations (range 2 to 8 sd=1.6). Demographic data, the joints operated on and the mean CRP values at the latest follow-up for each group are presented in Table 1 . No patient underwent a repeated revision arthroplasty, with exchange of the cemented prosthesis, at 5year follow-up (range from 72 to 82 months, sd=3.3), because of either infection or loosening. There was no reinfection among patients of the PJI group despite that PJI being caused by multiple pathogens leading to mixed infections in 33 % (6/18) of the cases. The causative germs of the PJI group, systemic antibiotic therapy as well as the local antibiotics in the bone cement are listed in Table 2 . Infection was prevented in the aseptic group comprising patients with a history of PJI or at higher risk of infection. Two patients underwent a superficial wound revision three and four months after one-stage septic knee exchange. Another patient was revised with exchange of the prosthesis head 1 year later due to recurrent hip dislocation after one-stage septic hip arthroplasty. Among the aseptic patients, only one patient underwent two re-operations due to loosening of the opposite component and polyethylene wear after 2 and 5 years, respectively. No patient developed a postoperative systemic allergy or hypersensitivity. Most of the patients (65 %) had a CRP value under 5 mg l
À1
, and 25.7 % patients had one between 5 and 10 mg l À1 . Only three patients showed an elevation of the CRP value above 10 (12 and 14 mg l À1 from the aseptic group and 24 mg l À1 from the PJI group). This was attributed to the comorbidity of all three patients rather than to a local infection of the affected joint, such as a concomitant renal disease, rheumatic disease, cardiac disease or diabetes. In all patients, the WBC count was normal. No patients had any local signs or symptoms of suspected PJI, such as fistula, erythema or pain exacerbation.
DISCUSSION
The combination of gentamicin and clindamycin in PMMA cement is recommended not only in septic revision cases where the antibiogram reveals sensitivity of the bacteria for both AB, but also in high-risk patients where the risk of infection is significantly higher than normal. Another indication for use could be those revision cases where the diagnosis is difficult, as in culture-negative PJI cases, or in those situations where anaerobic bacteria such as Cutibacterium acnes cannot be ruled out [9] . In such low-grade infections, the clinical and radiological signs of PJI are often not conclusive, and the pathogen may be isolated from the intraoperative biopsies or using sonication rather than in the synovial fluid preoperatively [16] .
We were able to show favourable results for the eradication of infection following the use of Copal G+C in one-stage septic exchange as well as the prevention of infection in high-risk patients with a minimum of 5 years follow-up. None of the patients in the PJI or aseptic groups required a revision due to PJI. It has been proven in vitro that the Copal G+C PMMA cement is more effective against biofilm formation than Palacos with only gentamicin [17] . Prior clinical studies with a shorter follow-up time period (one year) reported a high success rate in treatment and prevention of infection using Copal G+C [11, 15] . A significant reduction in the incidence of superficial and deep infections with the use of Copal G+C instead of Palacos R+G in hemiarthroplasty procedures in intracapsular neck fractures was reported [18] [19] [20] . In another clinical study by Gehrke et al., infection control was achieved in all analyzed patients after one-stage septic revision hip arthroplasty during an observation period of one year. Despite the high local concentration of gentamicin and clindamycin, systemic side-effects are not a concern as both ABs only peak transiently in the serum and urine after local use of Copal G+C and then quickly fall below detectable levels [11, 12, 21] . This recorded high success rate in the eradication of PJI as well as in prevention of infection in high-risk patients with the use of Copal G+C could be attributed to the predominantly bacteriostatic effect of clindamycin on Gram-positive bacteria such as staphylococci and streptococci and on Gram-positive and Gram-negative anaerobes, as well as to the synergetic effect of the combination of gentamicin and clindamycin, as Copal G+C showed the highest release rate of gentamicin after 7 days (>3 mg g À1 ) among the cements tested [10, 12] . Villanueva et al. prefer therefore dual ALBCs that elute the highest dose and add further antimicrobial substances to Copal G+C [11] . After 6 weeks, high local AB concentrations were measured in the tissue surrounding the spacer during two-stage septic exchange using Copal G+C. The antibiotic concentration was at least 5 µg g À1 and reached up to 100 µg g À1 [22] . The combination of gentamicin and clindamycin in PMMA cements has a theoretical antimicrobial effect on more than 90 % of the bacteria common to infected arthroplasties [8, 10, 12] . Additionally, due to the small molecular size of clindamycin, it shows a very good bone penetration with intracellular bactericidal activity depending on the organism and drug concentration [10, 23] .
The adding of further antibiotics to the Copal G+C was performed according to the recommendation of our infectious disease consultant individually. For example, vancomycin was added in a case of extensive PJI of the hip with a sinus tract and osteomyelitis of the proximal femur. Homogeneity of the mixture and particle size of antibiotic powder admixed determine the elution properties and also the mechanical alteration of the bone cement [7, 8] . Due to its excellent antimicrobial effect, Copal G+C seems to be ideal for articulating spacers, which are removed from the joint after a few weeks, but it is not as appropriate as Palacos R+G for definitive reimplantation once the infection has been cured. This conclusion is based on the results of an in vitro study that revealed that the incorporation of gentamicin in amounts greater than 0.5 g significantly reduces the mechanical properties of the bone cement [24] . However, according to our results and experience, G+C bone cement has also a good mechanical stability, as none of the investigated patients underwent a revision arthroplasty due to loosening. Furthermore, the available radiographs showed no signs of loosening at latest follow-up.
The current study has clear limitations. First, not all patients had a radiological follow-up examination. Second, the main limitation of this retrospective analysis was the high rate of loss to follow-up (70.4 %). The vast majority of the lost to follow-up cases were due to the advanced age at the time of surgery at our institution. Another limitation was the absence of clinical follow-up examinations and the fact that only patient history and laboratory blood tests were used to exclude PJI. However, the main goal of the study was to evaluate the revision rate with special focus on infection at a mid-term follow-up as an indication of the successful management.
In conclusion, this retrospective review revealed that the local use of Copal G+C bone cement as part of the surgical and microbiological management of septic and aseptic revision arthroplasty was associated with a high success rate for eradication of infection following one-stage septic exchange, including mixed forms, and with the prevention of infection rate in high-risk patients. However, in order to come to a definite conclusion, further studies with larger sample sizes are warranted.
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